October 18, 2021
Home Archive by category Johnson & Johnson
anthrax Clyburn COVID-19 cross contamination Emergent BioSolutions fda Infectious disease Johnson & Johnson Maloney public health Science Technology vaccines

Contractor that ruined 15M doses of J&J vaccine hiked price of another by 800%

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's COVID-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Getty | Saul LoebThings are not looking good for Emergent BioSolutions, the contract manufacturer that ruined 15 million doses of Johnson & Johnson’s one-shot COVID-19 vaccine and millions mo...
CDC COVID-19 fda hesitance Johnson & Johnson poll public health Science Technology vaccine

Pause of J&J vaccine was the right call, say 88% of polled Americans

Enlarge / General exterior view of the head office of Janssen pharmaceutical company on April 15, 2021 in Leiden, Netherlands. Getty | BSR AgencyAbout 88 percent of Americans support the pause of Johnson & Johnson’s COVID-19 vaccine, and the pause did not increase vaccine hesitancy, according to fresh data from the Axios-Ipsos Coronavirus poll....
CDC Coronavirus COVID-19 fda Infectious disease Johnson & Johnson pandemic SARS-CoV-2 Science Technology vaccine

More J&J troubles: Vaccine manufacturing halted and more possible clot cases

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Getty | Saul LoebThe US Food and Drug Administration last week asked Emergent BioSolutions to stop making Johnson & Johnson’s COVID-19 vaccine at its troubled facility in Baltimore, according...
ACIP CDC COVID-19 CVST Johnson & Johnson platelets Science Technology vaccine

CDC expert panel punts on deciding fate of J&J COVID vaccine

Enlarge / Boxes of Johnson & Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida.Getty | Paul HennessyAn advisory committee for the Centers for Disease Control and Prevention declined to vote on the fate of Johnson & Johnson’s COVID-19 vaccine Wednesday, likely leaving in place a pause on the vaccine’s use until the committe...
Astrazeneca CDC clotting COVID-19 fda Johnson & Johnson medicine Science Technology vaccine

J&J COVID vaccine use paused due to one-in-a-million complication

Enlarge / A nurse practitioner named Heidi Johnson administers a vaccine from Johnson & Johnson.Tom Williams / Getty ImagesOn Tuesday morning, the US Centers for Disease Control and Food and Drug Administration issued a release acknowledging an extremely rare clotting disorder was associated with the use of the Johnson & Johnson COVID vacci...
adenovirus Astrazeneca clotting COVID-19 EMA heparin immune response Johnson & Johnson platelets Science Side effects Technology vaccine

AstraZeneca vaccine linked to rare blood clots, EU regulators conclude

Enlarge / Vials of the AstraZeneca COVID-19 vaccine are seen during the opening of a vaccination center in Cyprus on March 22, 2021. Getty | Etienne TorbeyEuropean medical regulators on Wednesday concluded that there is a strong link between AstraZeneca’s COVID-19 vaccine and life-threatening conditions involving the unusual combination of blood cl...